On the other hand, toceranib phosphate, a tyrosine-kinase inhibitor, licensed for use in dogs, is primarily recommended for the treatment of canine mast cell tumors due to its inhibition of the receptor KIT. Here, KIT is linked to mast cell neoplasm.